Cuddeback, David A.

United States of America

Back to Profile

1-3 of 3 for Cuddeback, David A. Sort by
Query
Aggregations
Date
2025 2
2024 1
IPC Class
A61K 31/05 - Phenols 3
A61K 31/12 - Ketones 3
A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA] 3
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid 3
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline 3
See more
Status
Pending 1
Registered / In Force 2
Found results for  patents

1.

Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation

      
Application Number 18410512
Grant Number 12403158
Status In Force
Filing Date 2024-01-11
First Publication Date 2025-09-02
Grant Date 2025-09-02
Owner CUDDEBACK, DAVID A. (USA)
Inventor
  • Cuddeback, David A.
  • Lynch, Thomas J.

Abstract

A phytochemical and nutraceutical composition and method for protection against a wide spectrum of viral and bacterial infections, including Covid-19, and for treatment of established infection and infectious inflammation. The composition includes a novel combination of vitamin, mineral, nutraceutical and phytochemical supplements. The composition of supplements and method may be compounded as a pill, tablet, powder, capsule or liquid be taken orally one or more times per day, and parenteral including nasal sprays and inhalers. Vitamin C and vitamin E along with zinc complexed with pyrithione or citrate are used in conjunction with nutraceuticals and phytochemicals provided, respectively, as immune boosters and antiviral agents along with anti-inflammatory nutraceuticals and phytochemicals.

IPC Classes  ?

  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/05 - Phenols
  • A61K 31/12 - Ketones
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/355 - Tocopherols, e.g. vitamin E
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/4525 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
  • A61K 33/30 - ZincCompounds thereof
  • A61K 36/15 - Pinaceae (Pine family), e.g. pine or cedar
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/233 - Bupleurum
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/324 - Boswellia, e.g. frankincense
  • A61K 36/328 - Commiphora, e.g. mecca myrrh or balm of Gilead
  • A61K 36/537 - Salvia (sage)
  • A61K 36/74 - Rubiaceae (Madder family)
  • A61K 36/82 - Theaceae (Tea family), e.g. camellia

2.

Composition for Prevention and Treatment of Bacterial and Viral Infections and Inflammation

      
Application Number 19011109
Status Pending
Filing Date 2025-01-06
First Publication Date 2025-05-01
Owner CUDDEBACK, DAVID A (USA)
Inventor
  • Cuddeback, David A.
  • Lynch, Thomas J.

Abstract

Compositions and methods for protecting against a wide spectrum of viral and bacterial infections, including Covid-19, and for treating established infection and infectious inflammation are described. The composition includes a novel combination of vitamins, minerals, nutraceuticals, and phytochemicals, which may be compounded as a pill, tablet, powder, capsule or liquid to be taken orally or via other administration routs one or more times per day, to serve as immune boosters, antibacterial agents, and antiviral agents along with providing anti-inflammatory effects in humans and animals.

IPC Classes  ?

  • A61K 33/30 - ZincCompounds thereof
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/05 - Phenols
  • A61K 31/12 - Ketones
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 31/355 - Tocopherols, e.g. vitamin E
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 31/4525 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
  • A61K 36/15 - Pinaceae (Pine family), e.g. pine or cedar
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 36/233 - Bupleurum
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/324 - Boswellia, e.g. frankincense
  • A61K 36/328 - Commiphora, e.g. mecca myrrh or balm of Gilead
  • A61K 36/537 - Salvia (sage)
  • A61K 36/74 - Rubiaceae (Madder family)
  • A61K 36/82 - Theaceae (Tea family), e.g. camellia

3.

Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation

      
Application Number 18094541
Grant Number 11896611
Status In Force
Filing Date 2023-01-09
First Publication Date 2024-02-13
Grant Date 2024-02-13
Owner CUDDEBACK, DAVID A. (USA)
Inventor
  • Cuddeback, David A.
  • Lynch, Thomas J.

Abstract

A phytochemical and nutraceutical composition and method for protection against a wide spectrum of viral and bacterial infections, including Covid-19, and for treatment of established infection and infectious inflammation. The composition includes a novel combination of vitamin, mineral, nutraceutical and phytochemical supplements. The composition of supplements and method may be compounded as a pill, tablet, powder, capsule or liquid be taken orally one or more times per day. Vitamin C and vitamin E along with zinc complexed with pyrithione or citrate are used in conjunction with nutraceuticals and phytochemicals provided, respectively, as immune boosters and antiviral agents along with anti-inflammatory nutraceuticals and phytochemicals.

IPC Classes  ?

  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 33/30 - ZincCompounds thereof
  • A61K 31/355 - Tocopherols, e.g. vitamin E
  • A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
  • A61K 36/82 - Theaceae (Tea family), e.g. camellia
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/233 - Bupleurum
  • A61K 36/324 - Boswellia, e.g. frankincense
  • A61K 31/375 - Ascorbic acid, i.e. vitamin CSalts thereof
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 36/15 - Pinaceae (Pine family), e.g. pine or cedar
  • A61K 36/537 - Salvia (sage)
  • A61K 31/4525 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
  • A61K 36/74 - Rubiaceae (Madder family)
  • A61K 36/185 - Magnoliopsida (dicotyledons)
  • A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/05 - Phenols
  • A61K 31/12 - Ketones
  • A61K 36/328 - Commiphora, e.g. mecca myrrh or balm of Gilead